This is a demo store. No orders will be fulfilled.

Elsilimomab (anti-IL-6), 白细胞介素 6 抑制剂

    应用:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • 宿主种属: 人(Human)
  • 种属反应性: 人(Human), 恒河猴(Rhesus monkey)
  • 亚型: Human IgG1
  • 偶联: Unconjugated
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
Ab179383-100μg
100μg 现货 Stock Image
Ab179383-1mg
1mg 现货 Stock Image
Ab179383-5mg
5mg 现货 Stock Image
Ab179383-10mg
10mg 期货 Stock Image

基本信息

产品名称 Elsilimomab (anti-IL-6), 白细胞介素 6 抑制剂
别名 艾西莫单抗 | 艾尔西莫单抗(抗 IL-6)
英文别名 Interleukin BSF 2 antibody | B cell differentiation factor antibody | B cell stimulatory factor 2 antibody | B-cell stimulatory factor 2 antibody | BSF 2 antibody | BSF-2 antibody | BSF2 antibody | CDF antibody | CTL differentiation factor antibody | Cyto
规格或纯度 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
宿主种属 人(Human)
特异性 IL6
种属反应性 人(Human),恒河猴(Rhesus monkey)
偶联 Unconjugated
作用类型 抑制剂
作用机制 白细胞介素 6 抑制剂

产品属性

克隆类型 重组抗体
Format Whole IgG
亚型 Human IgG1
轻链亚型 kappa
SDS-PAGE 27.4 kDa (Light Chain) & 51.4 kDa (Heavy Chain), under reducing conditions; 191.6 kDa, under non-reducing conditions.
纯化方法 Protein A purified
纯度 >95%
物理外观 Liquid
储存缓冲液 Supplied as a 0.22 μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂 No
浓度 见COA
储存温度 -80℃储存,避免反复冻融
运输条件 超低温冰袋运输
稳定性与储存 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
CAS编号和信息 468715-71-1
分子类型 抗体

关联靶点(人)

IL6 Tclin 白细胞介素-6(Interleukin-6) (0 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

图片

Elsilimomab (anti-IL-6) (Ab179383) - ELISA
Immobilized Recombinant Human IL-6 Protein (rp156005) at 2.0 μg/mL can bind Elsilimomab (anti-IL-6) (Ab179383) with the EC₅₀ of 46.66 ng/mL.

Elsilimomab (anti-IL-6) (Ab179383) - SEC
The purity of Elsilimomab (anti-IL-6) (Ab179383) is more than 95% verified by HPLC.

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到3个结果

批号(Lot Number) 证书类型 货号
ZJ24F0404200 分析证书 Ab179383
ZJ24F0404201 分析证书 Ab179383
ZJ24F0404202 分析证书 Ab179383

可替换产品

引用文献

1. Boulanger MJ, Chow DC, Brevnova EE, Garcia KC.  (2003)  Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex..  Science,  300  (5628): (2101-4).  [PMID:12829785]
2. Shaw S, Bourne T, Meier C, Carrington B, Gelinas R, Henry A, Popplewell A, Adams R, Baker T, Rapecki S et al..  (2014)  Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signaling..  MAbs,  (3): (774-82).  [PMID:24670876]
3. Kang S, Tanaka T, Narazaki M, Kishimoto T.  (2019)  Targeting Interleukin-6 Signaling in Clinic..  Immunity,  50  (4): (1007-1023).  [PMID:30995492] [10.1016/j.immuni.2019.03.026]
4. Q Y Chen.  (1992-09-01)  [Stable and efficient expression of human interleukin-6 cDNA in mammalian cells after gene transfer]..  Zhonghua zhong liu za zhi [Chinese journal of oncology],  14  ((5)): (340-344).  [PMID:1291290]
5. H C van Zaanen,R P Koopmans,L A Aarden,H J Rensink,J M Stouthard,S O Warnaar,H M Lokhorst,M H van Oers.  (1996-09-15)  Endogenous interleukin 6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop..  The Journal of clinical investigation,  98  ((6)): (1441-1448).  [PMID:8823310]
6. Kim D, Won HY, Hwang ES, Kim YK, Choo HP..  (2017)  Synthesis of benzoxazole derivatives as interleukin-6 antagonists..  Bioorg Med Chem,  25  (12): (3127-3134).  [PMID:28442260] [10.1016/j.bmc.2017.03.072]
7. May, L T LT, Shaw, J E JE, Khanna, A K AK, Zabriskie, J B JB and Sehgal, P B PB..  (1991)  Marked cell-type-specific differences in glycosylation of human interleukin-6..  Cytokine,  [PMID:1883960]
8. Lütticken, C C, Krüttgen, A A, Möller, C C, Heinrich, P C PC and Rose-John, S S..  (1991)  Evidence for the importance of a positive charge and an alpha-helical structure of the C-terminus for biological activity of human IL-6..  FEBS letters,  (6): [PMID:2037043]
9. Clogston, C L CL, Boone, T C TC, Crandall, B C BC, Mendiaz, E A EA and Lu, H S HS..  (1989)  Disulfide structures of human interleukin-6 are similar to those of human granulocyte colony stimulating factor..  Archives of biochemistry and biophysics,  [PMID:2472117]
10. Ming, J E JE, Cernetti, C C, Steinman, R M RM and Granelli-Piperno, A A..  (1989)  Interleukin 6 is the principal cytolytic T lymphocyte differentiation factor for thymocytes in human leukocyte conditioned medium..  The Journal of molecular and cellular immunology : JMCI,  [PMID:2610854]
11. Tonouchi, N N, Miwa, K K, Karasuyama, H H and Matsui, H H..  (1989)  Deletion of 3' untranslated region of human BSF-2 mRNA causes stabilization of the mRNA and high-level expression in mouse NIH3T3 cells..  Biochemical and biophysical research communications,  (15): [PMID:2789513]
12. Zilberstein, A A, Ruggieri, R R, Korn, J H JH and Revel, M M..  (1986)  Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines..  The EMBO journal,  [PMID:3023045]
13. Wong, G G GG, Witek-Giannotti, J J, Hewick, R M RM, Clark, S C SC and Ogawa, M M..  (1988)  Interleukin 6: identification as a hematopoietic colony-stimulating factor..  Behring Institute Mitteilungen,  [PMID:3266463]
14. Van Damme, J J and 5 more authors..  (1988)  Separation and comparison of two monokines with lymphocyte-activating factor activity: IL-1 beta and hybridoma growth factor (HGF). Identification of leukocyte-derived HGF as IL-6..  Journal of immunology (Baltimore, Md. : 1950),  (1): [PMID:3279116]
15. Brakenhoff, J P JP, de Groot, E R ER, Evers, R F RF, Pannekoek, H H and Aarden, L A LA..  (1987)  Molecular cloning and expression of hybridoma growth factor in Escherichia coli..  Journal of immunology (Baltimore, Md. : 1950),  (15): [PMID:3320204]
16. Yasukawa, K K and 6 more authors..  (1987)  Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene..  The EMBO journal,  [PMID:3500852]
17. May, L T LT, Helfgott, D C DC and Sehgal, P B PB..  (1986)  Anti-beta-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the beta 2 interferon involved..  Proceedings of the National Academy of Sciences of the United States of America,  [PMID:3538015]
18. Haegeman, G G and 5 more authors..  (1986)  Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts..  European journal of biochemistry,  (15): [PMID:3758081]
19. Breton, J J and 8 more authors..  (1995)  Structure, stability and biological properties of a N-terminally truncated form of recombinant human interleukin-6 containing a single disulfide bond..  European journal of biochemistry,  (15): [PMID:7851440]
20. Nishimura, C C, Watanabe, A A, Gouda, H H, Shimada, I I and Arata, Y Y..  (1996)  Folding topologies of human interleukin-6 and its mutants as studied by NMR spectroscopy..  Biochemistry,  (9): [PMID:8555185]
21. Somers, W W, Stahl, M M and Seehra, J S JS..  (1997)  1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling..  The EMBO journal,  (3): [PMID:9118960]
22. Xu, G Y GY and 6 more authors..  (1997)  Solution structure of recombinant human interleukin-6..  Journal of molecular biology,  (2): [PMID:9159484]
23. Fishman, D D and 6 more authors..  (1998)  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis..  The Journal of clinical investigation,  (1): [PMID:9769329]
24. Foster, C B CB and 11 more authors..  (2000)  An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus..  Blood,  (1): [PMID:11001912]
25. Ota, N N and 8 more authors..  (2001)  A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density..  Journal of human genetics,  [PMID:11355017]
26. Chung, Hye Won HW and 8 more authors..  (2003)  Association of interleukin-6 promoter variant with bone mineral density in pre-menopausal women..  Journal of human genetics,  [PMID:12768442]
27. Nakahara, Hideko H and 6 more authors..  (2003)  Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis..  Arthritis and rheumatism,  [PMID:12794819]
28. Nemeth, Elizabeta E and 6 more authors..  (2004)  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin..  The Journal of clinical investigation,  [PMID:15124018]
29. Wolsk, Emil E, Mygind, Helene H, Grøndahl, Thomas S TS, Pedersen, Bente K BK and van Hall, Gerrit G..  (2010)  IL-6 selectively stimulates fat metabolism in human skeletal muscle..  American journal of physiology. Endocrinology and metabolism,  [PMID:20823453]
30. Taniguchi, Koji K and 17 more authors..  (2015)  A gp130-Src-YAP module links inflammation to epithelial regeneration..  Nature,  (5): [PMID:25731159]
31. Tagliabracci, Vincent S VS and 14 more authors..  (2015)  A Single Kinase Generates the Majority of the Secreted Phosphoproteome..  Cell,  (18): [PMID:26091039]
32. Larsen, Jakob Vejby JV and Petersen, Claus Munck CM..  (2017)  SorLA in Interleukin-6 Signaling and Turnover..  Molecular and cellular biology,  (1): [PMID:28265003]
33. Hirano, T T and 9 more authors..  (1986)  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin..  Nature,  [PMID:3491322]

溶液计算器